Nimotuzumab Combined With Paclitaxel for Recurrent Metastatic Gastric or Esophagogastric Junction Adenocarcinoma
Condition(s):Gastric or Esophagogastric Junction AdenocarcinomaLast Updated:August 7, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Gastric or Esophagogastric Junction AdenocarcinomaLast Updated:August 7, 2023Not yet recruiting
Condition(s):Nutritional Status; Gastrointestinal Cancer; ChemoradiotherapyLast Updated:September 18, 2017Unknown status
Condition(s):Gastroesophageal Reflux DiseaseLast Updated:October 19, 2010Completed
Condition(s):Peritoneal Carcinomatosis; Peritoneal Metastases; Appendix Cancer; Appendix Neoplasm; Colorectal CancerLast Updated:December 12, 2023Recruiting
Condition(s):Gastric Cancer; Colorectal Cancer; Pancreatic Cancer; Biliary CancerLast Updated:July 13, 2021Terminated
Condition(s):Neoplasm MalignantLast Updated:February 17, 2016Completed
Condition(s):Clinical Stage I Gastric Cancer AJCC v8; Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage II Gastric Cancer AJCC v8; Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage III Gastric Cancer AJCC v8; Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8; Clinical Stage IVA Gastric Cancer AJCC v8; Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8; Gastric Adenocarcinoma; Gastroesophageal Junction AdenocarcinomaLast Updated:March 12, 2024Recruiting
Condition(s):Metastatic Cancer; Melanoma; Gastric Cancer; Gastroesophageal Junction Adenocarcinoma; Colorectal CancerLast Updated:August 29, 2023Completed
Condition(s):Head and Neck Cancer; Lung CancerLast Updated:December 19, 2022Recruiting
Condition(s):NeoplasmsLast Updated:August 6, 2007Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.